RUHVENILE BIOMEDICAL OPC PRIVATE LIMITED

In their own words

www.ruhvenile.comRuhvenile is an Indian startup company (DIPP 29327) and having a DSIR recognized Research and Development Centre in New Delhi India. Ruhvenile is known for its ability to develop indigenous products through research and development with its own national international experienced scientific strength. Ruhvenile has received several grants including BIRAC-BIG , BIRAC-GG grants and established international and national collaborations to develop novel products to fulfil the unmet needs of our society. Ruhvenile has also received NIDHI4COVID2.0, NIDHIPrayas and EIR grants from Department of Science and Technology, Government of India for its innovative work and and one of the innovation has been recognized as a national importance to combat present. and future pandemic.Ruhvenile has a Research and Development Centre in New Delhi that has been recognized by Department of Scientific ad Industrial Research (DSIR), Government of India. BiomLife® is the first-of-its-kind product in India, and possibly the world, that serves as a universal transport liquid media suitable for a wide range of microbiological samples, including SKIN, GUT, FECAL, ORAL, VAGINAL, LIVER, BRAIN, and more. It has numerous USPs that set it apart from traditional methods of specimen collection and preservation:Maintains the viability of all kinds of microbes (bacteria, viruses, fungi, and parasites), including both aerobic and anaerobic microbes, in the same media. This is a challenging task that BiomLife® has successfully overcome.Maintains the integrity of microbial DNA/RNA (internal) and other biological metabolites, ensuring accurate and reliable analysis.Provides specimen stability without the immediate need for cold chain facilities, making it user-friendly. BiomLife® with specimens can be stored at room temperature for up to 48 hours, at 4°C for up to 7 days, at -20°C for up to 90 days, and at -80°C for a minimum of 550 days or 1.5 years.Preserves the viability of fastidious and low abundance microbes, enabling advanced microbiome profiling such as PCR, RT-PCR, Genome Sequencing, Metagenomics, Metabolomics, Proteomics, Functional Genomics, and many more, to generate accurate and reliable data for the diagnosis of infectious diseases.Ruhvenile is investing heavily to develop novel indigenous products/technologies for the world.

Written by the company on its public Startup India profile. Not verified by us.